Thirty blood samples were collected from people infected with HCV and collected 30 blood samples from healthy individuals as a control group. The samples were collected from the virus department at Diwaniyah Teaching Hospital,
INTRODUCTION
Viral hepatitis is one of the most important public health problems caused by HCV (Shrivastava, 2013) . Which leads to acute and chronic diseases and is a signi icant factor in liver cirrhosis and liver cancer (Heidari et al., 2016; Alsudani and Al-Shibli, 2015; Demirturk et al., 2014) .
The survival and persistence of the virus and differences in the clinical outcome of HCV infection are linked to the genetic factors affecting the development of liver disease and the polymorphism of cytokines that signi icantly affect the development of HCV (Conde et al., 2014; Dondeti et al., 2016) . Host response to hepatitis viruses involves various components of the immune system and these components, interleukins which play an essential role in identifying the infected cell and then regulate the immune and in lammatory response. Thus, eliminating the virus and destroying the infected cell (Kwon et al., 2014) ; Of these cytokines, IL-6 is located on chromosome 7 and contains (5 oxons and 4 introns) and IL-10 situated on the irst human chromosome (Zhai et al., 2017; Suryanarayanan et al., 2016) . These interleukins play an essential role in immune defences against HCV infection. They are produced by a wide range of cells such as T helper 1 and T helper 2. Where Th1 produces proin lammatory cytokines such as IL-6, which plays an essential role in eliminating intracellular injury. Th2 produces anti-in lammatory cytokines such as IL-10, which plays a role in regulating the humoral immune response. Controlling on the production of these cytokines are a very complicated process, the imbalance in the production of proin lammatory and anti-in lammatory interleukins signi icantly affects on development and persistence of infection with hepatitis C virus (M, 2011) . Our current study deals with the relationship between gene polymorphism of IL-6 and IL-10 and infection with hepatitis C virus through the following aspects ,which includes screening for antibodies to the hepatitis C virus and detection of gene polymorphism of IL-6 and IL-10 Using RFLP-PCR technology and its relationship to the spread of the hepatitis C virus (Alsudani, 2017; Lu et al., 2016) (Rüstemoğlu et al., 2016) .
MATERIALS AND METHODS

Study Design
Samples Collection: 60 blood samples were collected randomly from patients arriving at the Diwaniyah Teaching Hospital, Women's Hospital and Educational Children, Blood Bank and Thalassemia Center in Diwaniya Governorate which includes 30 patients infected with HCV (14 female and 16 male) and 30 people who were considered as control group (12 female and 18 male) for the period from July 2018 to February 2019. Blood samples were collected by venipuncture and the size of 5 ml per sample, 2.5 ml of blood sample was placed in a test tube and left about half an hour for the purpose coagulation and then separated the serum using centrifuged at 3000 cycles / minute for 15 minutes and then save the serum in ependrof tubes in the freezer for HCV diagnosis.
DNA primers
Use two types of primers to identify the IL-6 gene and the IL-10 gene and the primers were supplied by Macrogen in Korea: Table 1 shows,
Preparation of polymerase chain reaction mixture
The polymerase chain reaction mixture was presented by using the PCR preMix kit supplied by the Korean Bioneer company and according to the company's instructions as inTable 2
The components of the polymerase chain reaction mixture were put in the PCR tubes itted with the kit and container on the rest of the PCR reaction components. Then, the tubes were mixed with the vortex for 5 seconds, then transferred to the PCR thermocycler.
Thermocycling Program for DNA Ampli ication PCR Thermocycler conditions
The Polymerase reaction was performed using PCR thermocycler, using the Monoplex PCR technique as in Table 3 Add the cutting enzyme for identify IL-10 genotypes at site 592:
Add the cutting enzyme to the PCR product of the IL-10 gene and according to the supplied company's instructions as in Table 4 Then the tubes were incubated at a temperature of 37 m for a whole night. Then, the samples were transferred using 2% agarose gel. The results were as follows: there were no pieces of output along 410bp for C allele and the presence of two parts of output along 234bp and 176bp for A allele.
Add the cutting enzyme for identify IL-6 genotypes at site 174:
Add the cutting enzyme to the PCR product of the IL-6 gene and according to the supplied company's instructions as in Table 5 The tubes were incubated at a temperature of 37 m for a whole night. Then, the samples were transferred using 2% agarose gel. The results are as the following: the presence of pieces of the product with length 117 bp, 22 bp and 17 PB for C allele and the presence of pieces of the product with a length of 17 bp and 139 bp for the G allele.
RESULTS AND DISCUSSION
Genotype of interleukin IL-10 in patients with HCV and control group.
The results of our current study showed no signi icant difference between IL-10 genotypes in patients with HCV and healthy individuals as a control group at the probability level p≤0.05. Genotype AC of IL-10 was increased in patients with HCV (53.3% ) compared with the control group, while genotype CC of IL-10 was decreasing in patients with HCV (20% ) compared to the control group, while no differences were recorded in the proportions between patients and control group who carry the AA genotype of IL-10 where the proportions were Equal in both cases as in theTable 6 . Figure 1 and Figure 2 shows, In terms of the distribution of IL-10 alleles in patients with HCV and control group, the results of the present study showed no signi icant differences between alleles A and C of IL-10 in patients with HCV and control group at the probability level p≤0.05. Allele A for IL-10 was increased in patients with HCV (53.3%) compared to the control group. Allele C for IL-10 was decreased in patients with HCV( 46.7% ) compared with the control group and as in Table 7 .
Our study shows that there is no signi icant relationship between gene polymorphism of IL-10 in site 592 and HCV infection, this study an approach to (Gao et al., 2011) ind no signi icant relationship between gene polymorphism of IL-10 in site 592 and HCV infection. And an approach to (Zhang et al., 2010) , which was found after 10 studies on 992 patients with HCV and 1123 people as the control group, showed no signi icant relationship between genotype AC at site 592 of IL-10 and the HCV infection while a study conducted by found a relationship between alleles A and C at site 592 for IL-10 and the infection with HCV.
Immune response to the host is an important indicator of HCV infection results. IL-10 plays an important role in the elimination of infection and is considered an anti-in lammatory cytokine. IL-10 is secreted by cells such as lymphocyte cell and macrophage cell (Dienz and Rincon, 2009) . A lot of evidence suggests that the gene polymorphism of IL-10, especially at site 592, is associated with HCV infection as well as in the elimination of HCV infection (Sun et al., 2013) . Genotype AC considered a risk factor for the progression of HCV infection (Świątek, 2012; Al-Grawi and Al-Awsi, 2018; Shamran et al., 2018) .
Genotypes of interleukin IL-6 in patients with HCV and control group.
The results of the present study show the signi icance of the difference in the distribution of IL-6 genotypes between patients with HCV and control group at the probability level p≤0.05. Genotype GG of IL-6 was increased in patients with HCV 63.3% compared to control group, genotype GC for IL-6 was decreased in patients with HCV 16.7% compared to control group .genotype CC for IL-6 was decreased in patients with HCV 20% compared to control group and as in Table 8 .
In terms of the distribution of IL-6 alleles in patients with HCV and control group. The results of the present study showed a signi icant difference between the presence of alleles C and G for IL-6 in patients with HCV and control group at the probability p≤0.05. Allele G for IL-6 was increased in patients with HCV 71.7% compared to control group, and allele C was decreased in patients with HCV 28.3% compared with a control group and as in Table 9 .
This study approach to (Dohan et al., 2019; Cussigh et al., 2011; Falleti et al., 2010; Chalap and Al-Awsi, 2019; Abdulhussein and Al-Awsi, 2019 ) they found that the genotype GG and allele G were increased in patients with HCV compared to control group.
CONCLUSION
The immune response to the host plays an important role in the outcome of HCV infection and the development of the disease as well Cytokines play an important role in the differentiation and activation of immune cells (Dohan et al., 2019) . They are also involved in various cellular processes such as reproduction, differentiation and control the balance between pro-in lammatory and anti-in lammatory pathways that affect the outcome and treatment against HCV (Ueyama et al., 2011) . IL-6 is located on the seven human chromosomes, It contains 5 exons and 4 introns (Rasmussen et al., 2013; Dohan et al., 2019; Al-Awsi et al., 2019) . A number of studies have found a relationship between the gene polymorphism for IL-6 at site 174 and HCV infection (Dohan et al., 2019) . While other studies have not found a relationship between gene polymorphism for IL-6 at site 174 and HCV infection (Park et al., 2003) . The differences in the gene polymorphism of IL-6 at site 174 were asymmetric and may be due to the large ethnic diversity in the world (Comanescu et al., 
